(Q44874958)

7 December 2017

0 references

Recent progress in multidrug delivery to cancer cells by liposomes (English)

1 reference

7 December 2017

Ran Mo

1

1 reference

PubMed ID

25118703

7 December 2017

Tianyue Jiang

series ordinal

2

1 reference

PubMed ID

25118703

7 December 2017

Zhen Gu

series ordinal

3

1 reference

7 December 2017

1 January 2014

1 reference

7 December 2017

1 reference

7 December 2017

9

1 reference

7 December 2017

8

1 reference

7 December 2017

1117-1120

1 reference

Current trends in the use of liposomes for tumor targeting

7 December 2017

1 reference

Guiding principles in the design of ligand-targeted nanomedicines.

21 January 2018

1 reference

Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

21 January 2018

1 reference

Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors

21 January 2018

1 reference

First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia.

21 January 2018

1 reference

Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model

21 January 2018

1 reference

Development of stealth liposome coencapsulating doxorubicin and fluoxetine

21 January 2018

1 reference

Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery

21 January 2018

1 reference

Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies

21 January 2018

1 reference

Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

21 January 2018

1 reference

Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug

21 January 2018

1 reference

Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy

21 January 2018

1 reference

Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome

21 January 2018

1 reference

Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC.

21 January 2018

1 reference

Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases

21 January 2018

1 reference

Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent

21 January 2018

1 reference

Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy.

21 January 2018

1 reference

Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells

21 January 2018

1 reference

Enhanced anticancer efficacy by ATP-mediated liposomal drug delivery

21 January 2018

1 reference

Gel-Liposome-Mediated Co-Delivery of Anticancer Membrane-Associated Proteins and Small-Molecule Drugs for Enhanced Therapeutic Efficacy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/NNM.14.62

1 reference

7 December 2017

1 reference

PubMed ID

25118703